Snowball logo
logo
4886

ASKA Pharmaceutical Holdings Co Ltd

4886 • TSE
¥2,052.00+¥1.00  (0.05%)
Estimate
P/E
10.7
EPS
191.11
Beta
0.442
Growth
Revenue, YoY
-1.46%
Net income, YoY
-57.19%
Forecast
P/E (FWD)
10.4
EPS (FWD)
197.8
Dividends
Dividend yield
3.12%
Annual payout
¥64.00
Next ex. div date
March 29, 27
Payout
29.81%
Dividend growth streak
4 y
Div.rating
About the company
Ticker
4886
ISIN
JP3119660003
Country
Japan
Sector (GICS)
Healthcare
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of internal medicine, obstetrics and gynecology, and urology; and research, manufactures, imports, exports, and sells veterinary medicines and medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; engages in the manufacturing, sales, import, and distribution of prescription drugs, over-the-counter drugs, health foods, and other products; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Frequently asked questions

What sector does ASKA Pharmaceutical Holdings Co Ltd (4886) operate in?

ASKA Pharmaceutical Holdings Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is ASKA Pharmaceutical Holdings Co Ltd (4886) current stock price?

As of the latest data, ASKA Pharmaceutical Holdings Co Ltd stock price is ¥2,052, with a previous close of ¥2,051. ASKA Pharmaceutical Holdings Co Ltd gained ¥1 in the last trading session, representing a 0.05% increase.

What is ASKA Pharmaceutical Holdings Co Ltd (4886) current market capitalization?

ASKA Pharmaceutical Holdings Co Ltd market cap is approximately 58.38 billion.

What is ASKA Pharmaceutical Holdings Co Ltd (4886) Earnings Per Share (EPS)?

The trailing EPS is ¥191, and the forward EPS is ¥198.

What is ASKA Pharmaceutical Holdings Co Ltd (4886) Price-to-Earnings (P/E) ratio?

ASKA Pharmaceutical Holdings Co Ltd current P/E ratio is 10.74, with a forward P/E of 10.37.

Does ASKA Pharmaceutical Holdings Co Ltd (4886) pay dividends?

Yes. ASKA Pharmaceutical Holdings Co Ltd pays semiannual dividends with an annualized yield of 3.12% and an estimated annual payout of ¥64 per share.

When is the next ex-dividend date for ASKA Pharmaceutical Holdings Co Ltd (4886)?

The next ex-dividend date is scheduled for March 29, 2027.

What is ASKA Pharmaceutical Holdings Co Ltd (4886) beta (volatility) score?

ASKA Pharmaceutical Holdings Co Ltd has a beta of 0.442, indicating lower volatility than the overall market.